MedPath

A randomised controlled study to assess the emotional needs and efficacy of a service to meet identified emotional needs of individuals with macular disease

Completed
Conditions
Age related macular disease
Eye Diseases
Registration Number
ISRCTN43918552
Lead Sponsor
South Devon Healthcare NHS Foundation Trust (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
128
Inclusion Criteria

1. Patients who are experiencing sight impairment through Age related Macular Disease (AMD) that requires initial registration as sight impaired
2. Voluntary informed consent given

Exclusion Criteria

1. Limited understanding of English
2. Diagnosis of dementia
3. Have severe learning disabilities
4. Have a current severe psychiatric illness
5. Sight impairment for reasons other than macular disease
6. Unable to give voluntary informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Psychological pathology, measured at baseline, 4 and 12 months: <br>1. Psychiatric status, assessed by the 28-item General Health Questionnaire (GHQ-28)<br>2. Hospital Anxiety and Depression Scale (HADS)<br>3. Risk of deliberate self-harm, assessed by Beck Hopelessness Scale (BHS)
Secondary Outcome Measures
NameTimeMethod
The following secondary outcomes will be measured at baseline, 4 and 12 months: <br>1. Quality of Life, assessed by the Macular Disease-dependent Quality of Life (MacDQoL) scale<br>2. Adjustment, assessed by the Impact of Events Scale (IES)<br>3. Coping strategies, assessed by the COPE questionnaire <br>4. Social support, assessed by the Social Support Questionnaire (SSQ)<br>5. Knowledge, support and satisfaction questionnaire
© Copyright 2025. All Rights Reserved by MedPath